KOP · DEEP VALUE BRIEFING

Koppers Holdings Inc. (KOP)

published May 7, 2026 · price now $46.14 · market cap $942M

AVOID · medium confidence — the research’s call on buying at the price it saw, not advice to you.

Information only, not investment advice. Written by AI research agents from SEC filings and market data, and it can be wrong. Check the model below before relying on any of it.

EXECUTIVE SUMMARY

  • Verdict: AVOID
  • The "Why": Koppers Holdings (KOP) is a mediocre, cyclical business trading squarely at its fair value ($42 price vs. $38-$44 intrinsic value estimates). It offers zero margin of safety.
  • The Red Flag: A 60% surge in Free Cash Flow (FCF) paired with a 10% drop in revenue is a classic hallmark of a temporary working-capital release (e.g., inventory drawdown), not durable owner earnings.
  • Buffett Reality Check: With a 9.8% ROE and 23.8% gross margin, KOP lacks an economic moat. We demand a wonderful business at a fair price, or a fair business at a wonderful price. KOP is a fair business at a perfectly fair price. Pass.

KEY ARGUMENTS SYNTHESIZED

  • The Risky/Bull Case (Cyclical Rerating): The market is treating KOP like a dead cyclical. However, with an 8.4% FCF yield, 6.9% net income growth, and active deleveraging, the stock is primed for a multiple expansion if revenue merely stabilizes.
  • The Safe/Bear Case (No Moat, No Margin): Hope is not a margin of safety. The top line is shrinking (-10% YoY). The massive FCF jump is likely an unsustainable working-capital illusion. Deleveraging is necessary precisely because the core business metrics (low ROE, low margins) offer no structural protection against cyclical downturns.
  • The Neutral Case (Wait for Proof): A pure "avoid" might miss a turnaround, but diving in now is reckless. Capital should only be deployed if KOP can prove FCF durability without working-capital distortions and show a bottoming in revenue.

RATIONALE & BUFFETT LENS Under a strict value investing framework, capital preservation is paramount. The Risky Analyst correctly notes that average businesses can produce above-average returns during cyclical transitions. However, as the Safe Analyst rightly counters, capturing that upside requires buying at a deep discount.

At ~$42, KOP is trading precisely within its estimated intrinsic value range ($38.54 FCF value; $44.07 Damodaran value). Without a discount, you are absorbing all the business risk (cyclicality, lack of pricing power) without downside protection. Furthermore, the divergence between shrinking revenue and spiking cash flow is highly indicative of temporary cycle-timing rather than structural moat-building. Technical breakouts and 0.00% exploratory positions by hedge funds (Point72) do not replace a fundamental margin of safety.

LEARNING FROM PAST MISTAKES Our most painful historic missteps in value investing stem from confusing a statistically cheap cyclical for a genuinely safe investment. We have previously fallen into the "value trap" of annualizing peak free cash flow in a declining revenue environment, only to realize the cash surge was a temporary inventory drawdown. Buying a heavily cyclical company near fair value on the promise of "balance sheet deleveraging" usually ends in permanent capital impairment when the macroeconomic cycle turns.

REFINED INVESTOR PLAN

  1. Maintain Stance: Keep Koppers on the AVOID list for active capital deployment. Do not chase the rerating narrative.
  2. Strict Watchlist Criteria: Relegate KOP to a passive monitor. We will not revisit this ticker unless two conditions are met:
  • Valuation: The market panics and prices the stock well below its $38 floor, offering a true margin of safety.
  • Operations: Top-line revenue stabilizes, and FCF conversion remains resilient after working capital normalizes over the next 2-3 quarters.

FINAL STANCE: AVOID

The model

Every input behind the value range, so you can check the work or change an assumption and redo it yourself. Computed deterministically from SEC filings (fiscal 2025), updated Oct 4, 2026; the market price was $46.14. Values are estimates, not predictions.

Free cash flow

Discounts reported free cash flow: operating cash flow minus capital expenditure.

Value per share: −$32.70 / $92.06 / $309.73 (conservative / base / optimistic)

Starting Free Cash Flow$126M
Growth: conservative / base / optimistic (2020–2025)-53.3% / 3.9% / 30.0%
Projection10 years
Discount rate9.4%
Terminal growth4.5%
Shares outstanding19M
The history the growth rates come from (15 years)
2011$38M
2012$42M
2013$40M
2014−$53M
2015$83M
2016$61M
2017$24M
2018−$44M
2019$66M
2020$46M
2021−$35M
2022−$16M
2023$8M
2024$21M
2025$54M

Two-stage FCFF (Damodaran)

Projects revenue, operating margin and reinvestment, then discounts free cash flow to the firm at the weighted cost of capital.

Value per share: $12.36 / $33.13 / $53.14 (conservative / base / optimistic)

Starting Damodaran FCFF$116M
Growth: conservative / base / optimistic (2011–2025)-2.9% / 1.8% / 5.2%
Projection10 years
Risk-free rate5.28%
Equity risk premium4.15%
Beta1.00
Cost of equity9.43%
After-tax cost of debt4.96%
Equity weight53%
WACC (discount rate)7.34%
Target operating margin (base)7.6%
High-growth stage5 years
Terminal growth2.5%
Shares outstanding20M

This briefing is from May 7, 2026. A fresh one re-reads the latest filings and prices; running it takes a free account.

Run a fresh briefing →Watch the video briefingGet the iPhone app

The Monday letter

One email a week: what great value investors bought and sold, and what we make of it.

Send me the DeepValues Monday letter, one email a week. I can unsubscribe at any time. Information only, not investment advice. Privacy